Special Focus Session

SF 2c - Imaging after treatment in head and neck cancer

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Roberto Maroldi, Concesio / IT

2
Prognostic value of imaging biomarkers for treatment outcome

Prognostic value of imaging biomarkers for treatment outcome

15:00Ann Dorothy King, Hong Kong / CN

3
Imaging head and neck cancer after chemoradiation therapy

Imaging head and neck cancer after chemoradiation therapy

15:00Steve Connor, London / UK

4
Immunotherapy in head and neck: expected and non-expected findings

Immunotherapy in head and neck: expected and non-expected findings

15:00Alexandra Borges, Lisbon / PT

5
NIRADS PET CT and MRI

NIRADS PET CT and MRI

15:00Barton F. Branstetter IV, Wexford / US

6
Post-treatment interactive cases presentation

Post-treatment interactive cases presentation

15:00Minerva Becker, Geneva / CH

This session will address four critical issues concerning imaging after head and neck cancer treatment. The first question focuses on grading the likelihood of recurrence by assigning a standardised value to each suspicious imaging feature, which is then added to a final scale. NIRADS will significantly improve patient classification homogeneity in multidisciplinary team analysis and treatment planning. The second issue concerns the extrapolation of imaging biomarkers that have been shown to help predict treatment outcomes. The following questions will be asked: Should pre-treatment imaging data be used to extract biomarkers? Could they be obtained early during (chemo)radiation treatment? The final two issues will focus on expected and unexpected changes in tumours and surrounding tissues (including organs at risk) due to chemoradiation- and immunotherapy.

5 min
Chairperson's introduction
Roberto Maroldi, Concesio / Italy
15 min
Prognostic value of imaging biomarkers for treatment outcome
Ann Dorothy King, Hong Kong / China
15 min
Imaging head and neck cancer after chemoradiation therapy
Steve Connor, London / United Kingdom
15 min
Immunotherapy in head and neck: expected and non-expected findings
Alexandra Borges, Lisbon / Portugal
15 min
NIRADS PET CT and MRI
Barton F. Branstetter IV, Wexford / United States
15 min
Post-treatment interactive cases presentation
Minerva Becker, Geneva / Switzerland
10 min
Panel discussion: How to practically organise the follow-up: my advice

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.

This session offers AI-generated subtitles.